External Content

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

(Bloomberg) -- Galenica Sante’s stock sale in April may have been one of 2017’s biggest European IPOs, but that’s no reason for the Zurich stock exchange to celebrate. Over the past eight years, more companies have decided to leave the exchange than new ones to join. While Zur Rose Group AG is set to start trading July 6 and Landis+Gyr may also seek an IPO, acquisitions will lead to the delisting of heavyweights including Actelion Ltd. and Syngenta AG.

To contact the reporter on this story: Mara Bernath in Zurich at mbernath1@bloomberg.net.

To contact the editors responsible for this story: Sheldon Reback at sreback@bloomberg.net, Zoe Schneeweiss, Eric Coleman

©2017 Bloomberg L.P.

Neuer Inhalt

Horizontal Line


subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.







Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!

Bloomberg